Chatelut, Etienne <br/><br/>
Setting the Dose of Checkpoint Inhibitors: The Role of Clinical Pharmacology.  [electronic resource] 

 -  Clinical pharmacokinetics  03 2020 
 - 287-296 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.1007/s40262-019-00837-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antineoplastic Agents, Immunological--pharmacokinetics<br/>B7-H1 Antigen--drug effects<br/>Biological Variation, Population<br/>CTLA-4 Antigen--drug effects<br/>Drug Administration Schedule<br/>Humans<br/>Immune Checkpoint Inhibitors--adverse effects<br/>Immunotherapy--methods<br/>Neoplasms--drug therapy<br/>Pharmacogenetics<br/>Pharmacology, Clinical<br/>Predictive Value of Tests<br/>Programmed Cell Death 1 Receptor--drug effects<br/>Treatment Outcome